ArticleAnnals of the rheumatic diseases2011

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

A Strangfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.